In a report released today, Alec Stranahan from Bank of America Securities maintained a Buy rating on Sana Biotechnology (SANA – Research ...

About a year after cutting staff by 29%, Sana Biotechnology will trim its workforce as it increases investment in its type 1 ...

Just three years removed from a lucrative IPO, the company will cut jobs for a third time and invest more heavily in cell ...

Sana Biotechnology has become the latest cell therapy biotech to shift resources from cancer to autoimmune diseases as part of a ...

On Tuesday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $3.39 which represents a decrease of $-0.37 or -9.84% from the prior close of $3.76. The stock opened at $3.5 and ...

Fintel reports that on November 5, 2024, JMP Securities downgraded their outlook for Sana Biotechnology (NasdaqGS:SANA) from ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sana Biotechnology (SANA – Research Report) ...

On Monday, Sana Biotechnology Inc (SANA) stock saw a modest uptick, ending the day at $3.92 which represents a slight increase of $0.16 or 4.26% from the prior close of $3.76. The stock opened at ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Sana Biotechnology's cash burn of US$285m is about 30% of its US$941m market capitalisation. That's not insignificant, and if the company had to sell enough shares to fund another year's growth at the ...

Archon Biosciences, co-founded by the winner of the 2024 Nobel Prize in Chemistry, emerged from stealth Wednesday with $20 million in seed capital.

Oct. 31, 2024 — As critical responders, macrophages can perceive helpful biotechnology as threats. If not created with the right materials or mechanical forces, these devices can trigger an ...